Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum-Reference-Cited by-同舟云学术

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

Published:2019-04-16 Issue:6 Volume:94 Page:697-709
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Cuker Adam¹^ORCID,Burnett Allison²,Triller Darren³,Crowther Mark⁴,Ansell Jack⁵,Van Cott Elizabeth M.⁶,Wirth Diane⁷,Kaatz Scott⁸

Affiliation:

1. Department of Medicine and Department of Pathology and Laboratory MedicinePerelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania

2. Department of Pharmacy Practice and Administrative Sciences, University of New Mexico Health Sciences Center Albuquerque New Mexico

3. WellScriptEd Consulting, Inc. Clifton Park New York

4. Department of MedicineMcMaster University Hamilton Ontario Canada

5. Department of Medicine, Zucker School of Medicine at Hofstra/Northwell Hempstead New York

6. Department of PathologyMassachusetts General Hospital Boston Massachusetts

7. Department of Cardiology, Grady Memorial Hospital Atlanta Georgia

8. Division of Hospital MedicineHenry Ford Hospital Detroit Michigan

Funder

Janssen Pharmaceuticals

Asahi Kasei Pharma Corporation

CSL Behring

Bristol-Myers Squibb Canada

Shionogi

LEO Pharma Research Foundation

Heart and Stroke Foundation of Canada

Shire

Pfizer

Novo Nordisk

Bayer

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25475

Reference68 articles.

1. Dabigatran prescribing information.https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed December 20 2018.

2. Rivaroxaban prescribing information.http://www.janssenlabels.com/package‐insert/product‐monograph/prescribing‐information/XARELTO‐pi.pdf?sitelink=prescribing+info&gclid=CjwKCAiAmO3gBRBBEiwA8d0Q4nZUMV4UHlLjo035X_WEleG6E7vlA0soPEvt8tjaMYqwZHvfKhBoYRoCnOYQAvD_BwE&gclsrc=aw.ds. Accessed December 20 2018.

3. Apixaban prescribing information.https://packageinserts.bms.com/pi/pi_eliquis.pdf. Accessed December 20 2018.

4. Edoxaban prescribing information.https://dsi.com/prescribing-information-portlet/getPIContent?productName=Savaysa&inline=true. Accessed December 20 2018.

5. Betrixaban prescribing information.https://www.bevyxxa.com/wp‐content/uploads/2017/11/BEVYXXA‐PI‐v.1.4.june2017‐text.pdf?gclid=CjwKCAiAmO3gBRBBEiwA8d0Q4iivOuUgKhrjV_RlF1VA9ckbhQBq5ZFnG8‐NrR8l9wqQdhSTWtN78BoCQvgQAvD_BwE. Accessed December 20 2018.

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I treat pediatric venous thromboembolism in the DOAC era;Blood;2024-02-01

2. Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients;Cancer;2024-01-30

3. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-24

4. Prevalence and Outcomes Associated with Idarucizumab Administration in Trauma Patients on Preinjury Dabigatran Therapy: Analyzing Clinical Utilization in 942 Patients from 74 Hospitals;2024-01-13

5. Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study;Health Science Reports;2024-01